Pontifax I+II

Pontifax is a venture capital investor with $120m of assets under management, focusing on the Israeli life sciences sector. Pontifax is chaired by Mr. Eli Hurvitz, Chairman of Teva Pharmaceutical Industries Ltd. Pontifax constitutes a unique vehicle for investments in the Israeli life sciences sector, and is characterized by long-term capital appreciation by venture type investments, in Israeli and Israeli-related high growth pharmaceutical, biotechnological and medical device companies.